The rebirth of psychedelic therapy: An integrative literature review

Authors

DOI:

https://doi.org/10.33448/rsd-v10i9.18122

Keywords:

Therapy; Rebirth; Psychedelic; Hallucinogens.

Abstract

Objective: This study is a general approach to psychedelic science and aims, from an integrative literature review, to contextualize the rebirth of psychedelic therapy. Methodology: By searching the electronic database Medical Publications (PubMed) and the Scientific Electronic Library (Scielo) with the descriptor in English: "psychedelic therapy", the articles that make up this work were selected. The research was conducted between January and May 2021. The inclusion criteria used were articles in English and Portuguese, published in the last 20 years and related to the research question. Results: 43 articles were found in the search in the databases. However, only 7 articles were selected for analysis according to the inclusion criteria. Conclusion: After analyzing the texts, it was possible to correlate several aspects and conclude that there are great perspectives and potentials in psychedelic therapy and that its rebirth takes place in a context of social transformations and unmet demands in psychotherapy.

References

Brasil (2020). Alucinógenos que podem curar. Scientific American Brasil. Disponível em: Acesso em: 11 de jan. 2021.

Daniel, J., & Haberman, M. (2018). Clinical potential of psilocybin as a treatment for mental health conditions. The mental health clinician, 7(1), 24–28. https://doi.org/10.9740/mhc.2017.01.024

Doblin, R. E. (2020). Regulation of the Medical Use of Psychedelics and Marijuana. Harvard.https://www.psychologytoday.com/files/attachments/90761/doblinharvard2000regulation-the-medical-use-psychedelics-and-marijuana.pdf

Garcia-Romeu, A., & Richards, W. A. (2018). Current perspectives on psychedelic therapy: use of serotonergic hallucinogens in clinical interventions. International review of psychiatry (Abingdon, England), 30(4), 291–316. https://doi.org/10.1080/09540261.2018.1486289

Gardner, J., Carter, A., O’brien, K., & Seear, K. (2019). Psychedelic-assisted therapies: the past, and the need to move forward responsibly. International Journal Of Drug Policy, 70X), 94-98, 2019. http://dx.doi.org/10.1016/j.drugpo.2019.05.019.

Grinspoon, L., & Bakalar, J. (1997). Psychedelic drugs reconsidered. New York Lindesmith Center.

Grof, S. (1997). Os psicodélicos na autoexploração e na psicoterapia. Associação Psicodélica do Brasil.

Hartogsohn I. (2018). The Meaning-Enhancing Properties of Psychedelics and Their Mediator Role in Psychedelic Therapy, Spirituality, and Creativity. Frontiers in neuroscience, 12, 129. https://doi.org/10.3389/fnins.2018.00129

Hofemann, A. (2017) LSD: My problem child 4th edition. Multidisciplinary Association for Psychedelic Studies.

James, W. (2017). As variedades da experiência religiosa. São Paulo: Cultrix.

Johnson M. W. (2018). Psychiatry might need some psychedelic therapy. International review of psychiatry (Abingdon, England), 30(4), 285–290. https://doi.org/10.1080/09540261.2018.1509544

Leary, T. (1983). Flashbacks: An Autobiography. Los Angeles: J.P. Tarcher.

Luoma, J. B., Sabucedo, P., Eriksson, J., Gates, N., & Pilecki, B. C. (2019). Toward a contextual psychedelic-assisted therapy: perspectives from acceptance and commitment therapy and contextual behavioral science. Journal Of Contextual Behavioral Science, 14(X), 136-145. http://dx.doi.org/10.1016/j.jcbs.2019.10.003.

Moreton, S. G., Szalla, L., Menzies, R. E., & Arena, A. F. (2020). Embedding existential psychology within psychedelic science: reduced death anxiety as a mediator of the therapeutic effects of psychedelics. Psychopharmacology, 237(1), 21–32. https://doi.org/10.1007/s00213-019-05391-0

Noorani, T., Garcia-Romeu, A., Swift, T. C., Griffiths, R. R., & Johnson, M. W. (2018). Psychedelic therapy for smoking cessation: Qualitative analysis of participant accounts. Journal of psychopharmacology (Oxford, England), 32(7), 756–769. https://doi.org/10.1177/0269881118780612

Rodrigues, S. (2016). Modulações de sentidos na experiência psicodélica: saúde mental e gestão autônoma de psicotrópicos prescritos e proscritos. Curitiba: CRV.

Ross S. (2018). Therapeutic use of classic psychedelics to treat cancer-related psychiatric distress. International review of psychiatry (Abingdon, England), 30(4), 317–330. https://doi.org/10.1080/09540261.2018.1482261

Sessa B. (2018). Why MDMA therapy for alcohol use disorder? And why now?. Neuropharmacology, 142, 83–88. https://doi.org/10.1016/j.neuropharm.2017.11.004

Strassman, R. (2000). DMT - the spirit molecule: a doctor's revolutionary research into the biology of near-death and mystical experiences. Rochester: Park Street Press.

Strassman R. J. (1996). Human psychopharmacology of N,N-dimethyltryptamine. Behavioural brain research, 73(1-2), 121–124. https://doi.org/10.1016/0166-4328(96)00081-2

Watts, R., & Luoma, J. B. (2020). The use of the psychological flexibility model to support psychedelic assisted therapy. Journal Of Contextual Behavioral Science, 15(X), 92-102.http://dx.doi.org/10.1016/j.jcbs.2019.12.004.

Published

31/07/2021

How to Cite

SANTOS, H. da C. .; MEDEIROS, C. I. S. . The rebirth of psychedelic therapy: An integrative literature review. Research, Society and Development, [S. l.], v. 10, n. 9, p. e48510918122, 2021. DOI: 10.33448/rsd-v10i9.18122. Disponível em: https://rsdjournal.org/index.php/rsd/article/view/18122. Acesso em: 23 sep. 2021.

Issue

Section

Health Sciences